|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Biological, Geological and Environmental Sciences, Cleveland State University, Cleveland, Ohio 44115, USA
2 Department of Biochemistry, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106, USA
3 Department of Molecular Genetics, Microbiology and Immunology, Robert Wood Johnson Medical School, The University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey 08854, USA
4 Department of Nutrition, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106, USA
5 Department of Microbiology and Immunology, Downstate Medical Center, State University of New York, Brooklyn, New York 11203, USA
| ABSTRACT |
|---|
|
|
|---|
3.27) 21 amino acid long N-terminal extension that is present in fungi. Here we report that replacement of yeast rpS5 with its human homolog yielded a viable yeast strain with a 20%–25% decrease in growth rate. This replacement also resulted in a moderate increase in the heavy polyribosomal components in the mutant strain, suggesting either translation elongation or termination defects, and in a reduction in the polyribosomal association of the elongation factors eEF3 and eEF1A. In addition, the mutant strain was characterized by moderate increases in +1 and –1 programmed frameshifting and hyperaccurate recognition of the UAA stop codon. The activities of the cricket paralysis virus (CrPV) IRES and two mammalian cellular IRESs (CAT-1 and SNAT-2) were also increased in the mutant strain. Consistently, the rpS5 replacement led to enhanced direct interaction between the CrPV IRES and the mutant yeast ribosomes. Taken together, these data indicate that rpS5 plays an important role in maintaining the accuracy of translation in eukaryotes and suggest that the negatively charged N-terminal extension of yeast rpS5 might affect the ribosomal recruitment of specific mRNAs.
Keywords: ribosomal protein S5(S7); E-site; eEF3; translation accuracy; IRES
| INTRODUCTION |
|---|
|
|
|---|
Eukaryotic ribosomal protein S5 belongs to a family of ribosomal proteins that includes bacterial rpS7. rpS5/rpS7 forms part of the exit (E) site on the small ribosomal subunit (Fig. 1A; Yusupov et al. 2001
; Spahn et al. 2004
) and cross-links to the E-site tRNA (Wower et al. 1993
; Doring et al. 1994
). rpS7 also contributes to the formation of the so-called mRNA exit channel and interacts with rpS11, which is located on the platform of the 30S subunit (Robert and Brakier-Gingras 2003
). This interaction was suggested to contribute to the structural rearrangements of the head of the 30S subunit during translation (Robert and Brakier-Gingras 2003
). Mutations that disrupt this interaction affect translational fidelity in Escherichia coli, leading to an increased capacity for frameshifting and readthrough (Robert and Brakier-Gingras 2003
). In addition, E. coli rpS7 initiates assembly of the 30S subunit by binding to 16S rRNA (Nowotny and Nierhaus 1988
; Fredrick et al. 2000
; Grondek and Culver 2004
). In contrast, very little is known about the function of rpS7s eukaryotic rpS5 counterpart. In Saccharomyces cerevisiae, rpS5 is represented by a single gene copy and is essential for cell viability (Ignatovich et al. 1995
). The bacterial rpS7/rpS11 interaction is not conserved in eukaryotes (rpS5/rpS14) (Robert and Brakier-Gingras 2003
) and the mRNA exit channel formed by the rpS5/rpS14 interaction is open in isolated yeast 40S subunits (Passmore et al. 2007
). Interestingly, eukaryotic rpS5 interacts with the cricket paralysis virus (CrPV) IRES (Pfingsten et al. 2006
; Schuler et al. 2006
) and was suggested to be one of the determinants that might facilitate recruitment of this IRES to the 40S subunit.
|
3.27) 21-amino acid long N-terminal extension that is present in fungi. To investigate the function of rpS5 and in particular the role of the negatively charged N-terminal extension of the yeast protein, we obtained and characterized a yeast strain in which yeast rpS5 was replaced by its human homolog. Our data suggest that rpS5 plays important roles in ensuring the efficiency of elongation, in maintaining the reading frame for translation, and in stop codon recognition and that the negatively charged N-terminal extension of yeast rpS5 might affect the ribosomal recruitment of specific mRNAs. | RESULTS |
|---|
|
|
|---|
The resulting pTEF_humanS5 (2µ, LEU2) plasmid was transformed into a diploid heterozygous yeast strain with a single disrupted copy of the RPS5 gene. Transformants were allowed to sporulate and tetrads were dissected. Tetrad dissection analysis revealed that all four spores were viable, however two of them gave rise to colonies growing at reduced rates (Fig. 2A). PCR analysis using chromosomal DNA isolated from all four clones showed that clones growing at reduced rates contained a disrupted copy of the yeast RPS5 gene (not shown). Thus, hrpS5 was the sole source of rpS5 in these two strains, and we therefore conclude that human rpS5 can substitute for its yeast homolog in vivo. The BY4743 strain transformed with the empty p425TEF plasmid (2µ, LEU2) gave rise to only two viable colonies after sporulation and tetrad dissection, confirming that rpS5 is essential for yeast viability (not shown). A haploid strain (BY47hS5) with the genotype (MATa his3–1, leu2–0, ura3–0, rps5::kanMX, <hrps5; LEU2, 2µ>) was used for further detailed characterization. This strain displayed slightly reduced (
20%–25%) growth rates in comparison with the WT strain BY4741 transformed with the empty p425TEF LEU2 when grown on either rich YEPD medium or minimal SD medium. The doubling time for this strain at 30°C in liquid YEPD glucose medium was found to be
2 h, while for the WT BY4741 strain it is about 1.5 h. The expression levels of yrpS5 and hrpS5 in the WT and the mutant yeast strain were determined by Western blotting using an antibody directed against the AIKKKDELERVAKSNRC C-terminally conserved rpS5 peptide (provided by Shuetsu Fukushi, BioMedical Laboratories, Saitama, Japan) that is able to recognize the yeast and the human protein. This analysis showed equal levels of expression of the rpS5 proteins in the two strains (Fig. 2B), validating comparisons of other aspects of translation in the two strains.
|
|
|
1.2–1.3-fold) for all three signals (Fig. 5A). To investigate whether nonsense suppression is also affected in the mutant strain, we employed similar dual-luciferase reporters each containing one of the stop codons (UAA, UAG, or UGA) inserted into the firefly luciferase gene so that firefly luciferase can only be produced as a result of a nonsense suppression (Harger and Dinman 2003
|
To investigate cap-dependent translation, we used a construct (p281), in which the lacZ gene is under control of the GAL1 promoter (Mueller et al. 1987
). LacZ expression in the mutant strain was reduced by
20%–25% compared to the WT strain (Fig. 6A). To study the effect of the yrpS5 substitution on yeast URE2 IRES-mediated expression, the previously described Ure2p–lacZ reporter system was employed, in which the URE2 IRES was inserted in frame in front of the lacZ reporter gene but behind a stable hairpin structure (
G >–30 kcal/mol), which nearly abolished cap-dependent lacZ expression (Komar et al. 2003
, 2005
). Expression from the URE2 IRES in the mutant strain was 25%–30% lower than in the WT strain (Fig. 6A), similar to the reduction observed for cap-dependent lacZ expression. These data indicate that the yrpS5 substitution did not specifically affect URE2 IRES-mediated expression. To investigate the activities of two mammalian IRESs in yeast, the SNAT-2 IRES (Gaccioli et al. 2006
) and the CAT-1 IRES (Fernandez et al. 2001
; Yaman et al. 2003
), these IRESs were cloned into the p281–4 vector behind the stable hairpin structure described above and fused to the lacZ reporter gene. The SNAT-2 and the CAT-1(-192) IRESs (Yaman et al. 2003
) were active in the WT yeast strain (Fig. 6A), and the activities of both SNAT-2 and CAT-1 IRESs were enhanced in the mutant yeast strain (Fig. 6A), suggesting that substitution of yrpS5 with its human homolog likely facilitated the recruitment of these IRESs to the yeast translational apparatus. No apparent differences in lacZ mRNA levels were observed between the WT and the mutant yeast strains (Fig. 6B).
|
1.3-fold higher than in the WT strain (Fig. 7A). To verify that the increase in the activity of the CrPV IRES in the mutant strain was due to enhanced affinity of the IRES to hrpS5-containing hybrid yeast ribosomes, the direct interaction between the CrPV IRES and the WT and mutant ribosomes was assayed by toeprinting. Gel electrophoresis and Western blotting confirmed that hrpS5 was a stable constituent of purified mutant 40S ribosomal subunits (Fig. 7A,B). Toeprinting analysis of a reaction mixture that contained the CrPV IRES and WT 40S subunits did not yield any detectable characteristic toeprint +15–17 nucleotides (nt) downstream from the P-site CCU codon (Fig. 7C), which indicated that the binding of CrPV IRES to WT yeast 40S subunits was either very inefficient or extremely unstable. In contrast, hrpS5-containing hybrid yeast 40S ribosomes yielded a weak characteristic stop at the +15–17 position (Fig. 7C), suggesting that the presence of hrpS5 enhanced the affinity of yeast 40S subunits to the CrPV IRES. However, very prominent toeprints at +15–17 nt downstream from the P-site CCU codon were observed for both WT and hybrid 80S ribosomes (Fig. 7C), but, again, the signal obtained with hybrid ribosomes was stronger. Comparison of the band intensities (normalized to the background) by the use of the ImageJ program (Wayne Rasband, NIH) showed that the toeprint from the hybrid 80S ribosomes is
1.33-fold stronger than that of the WT 80S. This correlates strongly with the in vivo
1.3-fold increased activity of the CrPV IRES in the mutant yeast strain (Fig. 7A). However, in contrast to higher eukaryotes, the CrPV IRES was found to bind stably only to yeast 80S ribosomes but not to yeast 40S subunits. Our data therefore suggest that the 21 amino acid long N-terminal extension of yrpS5 has a negative effect on the interaction of the CrPV IRES RNA with the yeast WT 40S subunits and 80S ribosomes.
|
| DISCUSSION |
|---|
|
|
|---|
The translational fidelity of the strain expressing the hybrid ribosomes was altered relative to the wild-type strain, displaying moderately increased levels of frameshifting as well as an altered ability to recognize the UAA stop codon. It has been proposed that the E-site is allosterically coupled to the A-site and that this coupling controls the ability of the ribosomes to discriminate between cognate and noncognate tRNAs at the A-site (Nierhaus 2006
). The observation that the translational fidelity of mutant ribosomes with a modified E-site was altered is consistent with this hypothesis. The reduced binding of eEF3 to mutant ribosomes, which favors binding of cognate aminoacyl-tRNA at the A-site (Uritani and Miyazaki 1988
) may also contribute to altered translational fidelity. A similar effect has been previously observed in the case of mutations in E. coli rpS7 (the bacterial rpS5 homolog), which disrupted its interaction with rpS11 (Robert and Brakier-Gingras 2003
). The authors likewise suggested that mutations in rpS7 might have impaired the coupling between the E- and the A-site and that this contributed to the reduced translation fidelity (Robert and Brakier-Gingras 2003
). Allosteric coupling between A- and E-sites has also been suggested to influence translation termination events (Nierhaus 2006
). Our experiments revealed the hyperaccurate (approximately twofold enhanced) recognition of a UAA stop codon in the mutant strain relative to the WT strain, whereas there was no significant change in the recognition of a UAG or UGA codon. The reason for the hyperaccurate recognition of UAA codons but not of other termination codons in the mutant strain is not clear. It might be that the relative positioning of UAA, UAG, and UGA codons in the ribosomal A-site differs slightly and that their recognition by eRF1 could be influenced by an aspect of ribosomal architecture, presumably altered in the mutant strain. Similar hyperaccurate recognition of the UAA codon has been recently reported in a mutant yeast strain containing undermodified rRNA bases (Baxter-Roshek et al. 2007
). It was proposed that the efficiency of recognition of the three stop codons might be critically dependent on the ribosome structure that can be affected by modifications of rRNA (Baxter-Roshek et al. 2007
). Modifications of rpS5 might have a similar effect.
We also investigated whether modifications to the E-site caused by heterologous replacement of rpS5 affected translation in an mRNA-specific manner. We focused on IRES-containing mRNAs, utilizing the CrPV IRES that functions in yeast (Thompson et al. 2001
) because it interacts primarily with the ribosomal E-site and because it has been suggested that rpS5 may play a critical role in recruiting this IRES to the 40S subunit (Pfingsten et al. 2006
; Schuler et al. 2006
). Indeed, toeprinting experiments indicated that purified mutant yeast ribosomes containing human rpS5 had an increased affinity to the CrPV IRES in vitro. This observation was supported by in vivo experiments showing increased levels of CrPV IRES activity in the mutant yeast strain under permissive conditions when eIF2GTPMet-tRNAMet i levels were reduced by constitutive overexpression of the GCN2 kinase. In sharp contrast to mammalian 40S subunits, the CrPV IRES does not bind stably to yeast 40S subunits, even to those containing human rpS5, but does bind to WT 80S yeast ribosomes and somewhat more strongly to mutant 80S ribosomes (Fig. 7C). This binding may account for the enhancement in translation mediated by this IRES in conditions that favor accumulation of 80S ribosomes. Direct and stable binding of the IRES to mammalian 80S ribosomes has been reported previously (Pestova et al. 2004
). Interestingly, two mammalian cellular IRESs (the SNAT-2 IRES and the CAT-1(-192) IRES) were active in yeast and mediated a higher level of translation in the mutant yeast strain than in the wild-type strain. The factors required for initiation on the SNAT-2 and the CAT-1 IRESs and the mechanism(s) of their recruitment to the ribosome are not known. In light of the importance of the E-site for the activity of other viral IRESs (e.g., Spahn et al. 2001b
), it is possible that the architecture of the E-site might also be critical for the activity of these cellular IRESs and that the presence of the homologous mammalian rpS5 might facilitate their recruitment to the yeast ribosome. However, the precise location of the 21 amino acids C-terminal extension of yeast rpS5 has not been determined, so that details of how it might affect IRES binding are not known. The resolution of cryo-EM reconstructions of yeast ribosomes (Spahn et al. 2001a
, 2004
) is not sufficient to visualize the rpS5 N-terminal extension. Interestingly, the N terminus of the homologous bacterial rpS7 points to the mRNA channel between the head and the platform (Fig. 1A; Yusupov et al. 2001
). It is tempting to speculate that the additional 50 N-terminal amino acids present in human rpS5 (and
70 amino acids present in yeast rpS5) might protrude into the mRNA channel and thus interfere with binding of some mRNAs. Taken together the data presented here indicate that eukaryotic rpS5 plays a role in a variety of ribosomal activities, including maintenance of the translation reading frame, recognition of stop codons as well as recruitment of specific mRNAs to the translational machinery.
| MATERIALS AND METHODS |
|---|
|
|
|---|
, his3–1/his3–1, leu2–0/leu2–0, lys2–0/+, met15–0/+, ura3–0/ura3–0, RPS5/rps5::kanMX). The human rpS5 strain BY47hS5 Mata his3–1, leu2–0, ura3–0, rps5::kanMX, <hrps5; LEU2, 2µ> and strain BY47hS51 MAT
his3–1, leu2–0, lys2–0, ura3–0, rps5::kanMX, <hrps5; LEU2, 2µ> were obtained as follows: cDNA of human ribosomal protein S5 was amplified by PCR using 5'-AACGCGGATCCGCTCAGGCTGTGTTCTCAG-3' and 5'-AAAAAAAAGTCGACGGCTGGGACTGCCCCAAAG-3' primers and pCMV-SPORT6 plasmid containing cDNA for human rpS5 (MGC-21949) as a template. The PCR fragment was further digested with BamHI and SalI and cloned into p425TEF (2µ, LEU2) (Mumberg et al. 1995
Yeast cultures were grown as indicated using either synthetic media containing 0.67% Difco yeast nitrogen base, 1% ammonium sulfate, 2% glucose (or galactose), and supplemented with the appropriate amino acids or YEPD medium (Rose et al. 1990
). Transformation was done using the lithium acetate method (Ito et al. 1983
). For polysome analysis, yeast cells were grown in YEPD medium with 2% glucose or galactose.
Plasmids
The p281 plasmid containing lacZ under GAL1/10 promoter has been described previously (Mueller et al. 1987
). The p281–4-URE2 and p281–4-URE2_CTT vectors have also been previously described (Komar et al. 2003
, 2005
). The p281–4-CAT-1(-192), p281–4-SNAT-2, and p281–4-CrPV plasmids were made by subcloning the respective IRES elements as XhoI-EcoRI or SacII-EcoRI fragments into the p281–4 plasmid (Altmann et al. 1993
). The CAT-1(-192) IRES (Yaman et al. 2003
) was amplified by PCR using 5'-AAAAACTCGAGCCTTGCAGGGGCGTGAAGCTACT-3' and 5'-AAAAAGAATTCTCATCGCGCTGAGCAAATCTGTCTG-3' primers. The SNAT-2 IRES (Gaccioli et al. 2006
) was amplified using 5'-AAAAACTCGAGCGACGCCGCCGCCTTAGAAC-3' and 5'-AAAAAGAATTCTCATGCTAAGCACTGGGAGGAATCGG-3' primers. PCR fragments were digested with XhoI and EcoRI and were cloned into the p281–4 vector. The CrPV-IGR IRES (Wilson et al. 2000
) was amplified by PCR using 5'-AAAAACCGCGGAAAAATGTGATCTTGCTTGTAAATACAATTTTGAG-3' and 5'-AAAAAGAATTCTAGCAGGTAAATTTCTTAGGTTTTTCGACTACCA-3' primers, digested with SacII and EcoRI and cloned into the p281–4 vector. The GCN2c-515 (GCN2c-E601K-E1606G) allele of GCN2 kinase (Ramirez et al. 1992
) in the p1054 plasmid was kindly provided by Dr. Tom Dever (NIH). This allele was cloned into pRS313 (CEN, HIS3) (Sikorski and Hieter 1989
) as a SalI-NotI fragment. Programmed –1 and +1 frameshifting test reporters containing L-A, Ty1, or Ty3 frameshift signals, respectively, between the Renilla and firefly luciferase genes and nonsense suppression test reporters containing three different stop codons (UAA, UAG, or UGA) in the firefly luciferase gene (Harger and Dinman 2003
, 2004
) were provided by Dr. Jonathan D. Dinman (University of Maryland). The monocistronic CrPV IGR IRES-containing transcription vector has been described (Wilson et al. 2000
). All luciferase reporter plasmids were transformed into WT and BY47hS5 strains and grown on the minimal YNB medium.
Semiquantitative RT-PCR analysis of RNA expression levels
The levels of IRES-containing RNA expressed from the respective p281–4 plasmids were assessed by RT-PCR analysis using the SuperScript system from Invitrogen. Total RNAs were extracted after glass bead yeast cell disruption using the TRIzol Reagent (Invitrogen). Prior to RT-PCR reactions the RNAs were additionally treated with DNAse I (Ambion) to remove possible DNA admixtures. The following oligonucleotide primers were used: 5'-GCGTGGCAGCATCAGGGG-3' and 5'-CGTGCAGCAGATGGCGATGGC-3' to amplify the lacZ containing mRNAs and 5'-GGACTTGAAGGACAAGCGTGTCTTC-3' and 5'-CCACCTAAGATGGCCAAGAATGGT-3' to amplify the phosphoglycerate kinase (PGK) mRNA for use as an internal control. No more than 25 amplification cycles were routinely used in the second PCR step.
Fractionation of polyribosomes and isolation of 40S and 60S subunits
Fractionation of polyribosomes was done essentially as described (Komar et al. 2005
). All procedures were performed at 4°C except where indicated. Yeast cells from 50 mL of log phase culture were pelleted, treated for 1 min with 10 µg/mL cycloheximide, and repelleted. Lysates were made by glass bead cell disruption (3–5 cycles of 1 min each), with intermittent cooling on ice, in buffer which contained 100 mM KCl, 2.5 mM magnesium acetate, 20 mM HEPESKOH, pH 7.4, 14.4 mM
-mercaptoethanol, 100 µg/mL cycloheximide. Cell debris was removed by centrifugation at 7000 rpm for 8 min. Polyribosomes, ribosomes, and subunits were resolved in either 7%–25% (20,000 rpm, 18 h) or 7%–50% (17,000 rpm, 18 h) sucrose gradients containing 100 mM KCl, 5 mM MgCl2, 20 mM HEPESKOH, pH 7.4, and 2 mM dithiothreitol using a Beckman SW32.1 rotor. Gradients were collected using the ISCO Programmable Density Gradient System with continuous monitoring at 254 nm using an ISCO UA-6 absorbance detector.
Individual 40S and 60S ribosomal subunits were purified as follows: Yeast cells were grown overnight in 1–1.5 L of YEPD medium to an OD600=1.5–2, pelleted at 6,000g for 10 min at 4°C and resuspended on ice in 10 mL cold breaking buffer (20 mM Tris/HCl pH 7.6, 50 mM KCl, 10 mM MgCl2, 0.1 mM EDTA, 1 mg/mL Heparin) and containing one complete EDTA-free protease inhibitor cocktail tablets (Roche)/50 mL buffer. Cells were disrupted using glass beads in a BeadBeater (BioSpec) for 3 x 1 min with intermittent cooling on ice. Cell debris was removed by centrifugation at 14,000g for 20 min at 4°C. The supernatant was layered on top of a 2 M sucrose solution in breaking buffer and the ribosomes were pelleted at 50,000 rpm for 18 h at 4°C using a Beckman 70Ti rotor. The ribosome pellet was resuspended in buffer A (20 mM Tris/HCl pH 7.6, 50 mM KCl, 4 mM MgCl2, 2 mM EDTA) containing 0.25 M sucrose to an OD260
100–150 a.u., and the KCl concentration was gradually increased to a final concentration of 0.5 M by adding 4 M KCl under conditions of continuous mixing for 30 min at 4°C using a magnet stirrer. The ribosomes were pelleted again at 60,000 rpm for 4.5 h at 4°C using a Beckman TLA 110 rotor. The pellet was resuspended in buffer A to an OD
50–100 a.u., incubated with 1 mM puromycin for 10 min at 4°C, and subsequently for 10 min at 37°C. 40S and 60S ribosomal subunits were resolved by centrifugation in 5%–25% sucrose gradients containing 500 mM KCl, 4 mM MgCl2, 2 mM EDTA, 20 mM Tris/HCl pH 7.6 (20,000 rpm, 18 h, Beckman SW32.1 rotor). Fractions containing 40S and 60S ribosomes were collected, concentrated using Centricon 50 microconcentrators (Millipore) and resuspended in buffer (20 mM Tris/HCl pH 7.6, 50 mM KCl, 2.5 mM MgCl2, 2 mM EDTA) containing 0.25 M sucrose. For Western blotting, proteins collected from sucrose gradient fractions were precipitated with 10% trichloroacetic acid (TCA) and resolved by 10% Laemmli SDS-polyacrylamide gel electrophoresis and then transferred onto Immobilon (Millipore) membranes.
Disruption of the YEF3 gene encoding eEF3
For the YEF3 gene disruption, the HIS gene was used. The cassette was amplified from the pRS423 plasmid using 5'-CTTTCCTTAATTGTTTTCTAAAGAACCGTGTATTTTTCTAGTTCGGGAGACGGTCACAGCTTGTCT-3' and 5'-ATTACAAAAACATAGAAATTAAAATATACATAAATTATTAGATCACGCCTCGTTCAGAATGACACGT-3' primers. The PCR fragment was transformed into BY47hS5 strain and disruptants were selected on C-His medium. The disruption was verified by PCR analysis of chromosomal DNA using primers 5'-GACTCCGTTTAATCACTTTCAACCGC-3' and 5'-GGGTATGAGGCAATGCTCAATTTG-3'. PCR amplification using these primers yielded a 3698 base-pair (bp) fragment if the WT gene was present and a 1765 bp fragment when disruption was successful and the YEF3 gene had been replaced with the HIS3 cassette (not shown).
Toeprinting
For toeprinting analysis, ribosomal complexes were assembled essentially as described (Pestova and Hellen 2003
); 2.5 pmol of CrPV IRES-containing mRNA were incubated with 3.5 pmol WT or mutant yeast 40S subunits in the presence or in the absence of 3.5 pmol yeast 60S subunits in 40 µL buffer containing 20 mM Tris pH 7.5, 100 mM potassium acetate, 2.5 mM magnesium acetate, 2 mM DTT, and 0.25 mM spermidine for 10 min at 37°C. Primer extension was done using AMV reverse transcriptase (Promega) and 32P-phosphorylated primer complementary to nt 6341–6359 of CrPV RNA. cDNA products were analyzed in a 6% polyacrylamide sequencing gel.
Western blotting
Western blotting was performed following standard procedures (Towbin et al. 1979
). Western blots were decorated with rabbit polyclonal anti-eEF3, anti-eEF1A, anti-rpS5, or anti-rpS2 antibodies followed by incubation with goat anti-rabbit HRP-conjugated antibodies. The anti-human S5 antibodies were raised in rabbits by United States Biological using a 16-mer peptide (MTEWETAAPAVAETPD) as an antigen. The antibodies to yeast rpS5 directed against the conserved C-terminal peptide (AIKKKDELERVAKSNRC) were kindly provided by Dr. Shuetsu Fukushi (BioMedical Laboratories, Saitama, Japan). The anti-S2 antibodies were kindly provided by Dr. Jonathan Warner (Albert Einstein College of Medicine, New York). The blots were then detected with an enhanced chemiluminescence detection kit (ECLTM, GE Healthcare).
Miscellaneous
Molecular cloning was performed following the general procedures described in Sambrook et al. (1989)
. DNA sequencing was accomplished by the Molecular Biology Core Laboratory at Cleveland State University. Sequencing was performed with custom synthesized oligonucleotides using the fluorescently labeled dideoxy terminator methodology. SDS-PAGE was performed according to Laemmli (1970)
. Yeast genomic DNA was isolated using the DNA-PureTM Yeast Genomic Kit (PureBiotech) and following the manufacturer's protocol.
-galactosidase activity was measured following the protocol described in the Clontech Yeast Protocols Handbook with o-nitrophenyl
-D-galactopyranoside as a substrate. Cell extracts were prepared by subsequent cycles of cell freezing in liquid nitrogen and thawing at 37°C. Luciferase activities were measured using a dual-luciferase assay kit (Promega) as described by Dinman and colleagues (Harger and Dinman 2003
, 2004
; Jacobs and Dinman 2004
).
| ACKNOWLEDGMENTS |
|---|
|
|
|---|
| Footnotes |
|---|
Article published online ahead of print. Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.688207.
Received June 14, 2007; accepted August 22, 2007.
| REFERENCES |
|---|
|
|
|---|
Altmann, M., Muller, P.P., Wittmer, B., Ruchti, F., Lanker, S., and Trachsel, H. 1993. A Saccharomyces cerevisiae homolog of mammalian translation initiation factor 4B contributes to RNA helicase activity. EMBO J. 12: 3997–4003.[Medline]
Anand, M., Balar, B., Ulloque, R., Gross, S.R., and Kinzy, T.G. 2006. Domain and nucleotide dependence of the interaction between Saccharomyces cerevisiae translation elongation factors 3 and 1A. J. Biol. Chem. 281: 32318–32326.
Andersen, C.B., Becker, T., Blau, M., Anand, M., Halic, M., Balar, B., Mielke, T., Boesen, T., Pedersen, J.S., Spahn, C.M., et al. 2006. Structure of eEF3 and the mechanism of transfer RNA release from the E-site. Nature 443: 663–668.[CrossRef][Medline]
Baxter-Roshek, J.L., Petrov, A.N., and Dinman, J.D. 2007. Optimization of ribosome structure and function by rRNA base modification. PLoS ONE 2: e174. doi: 10.1371/journal.pone.0000174.[CrossRef]
Beringer, M. and Rodnina, M.V. 2007. The ribosomal peptidyl transferase. Mol. Cell 26: 311–321.[CrossRef][Medline]
Bertram, G., Bell, H.A., Ritchie, D.W., Fullerton, G., and Stansfield, I. 2000. Terminating eukaryote translation: Domain 1 of release factor eRF1 functions in stop codon recognition. RNA 6: 1236–1247.[Abstract]
Brodersen, D.E. and Nissen, P. 2005. The social life of ribosomal proteins. FEBS J. 272: 2098–2108.[CrossRef][Medline]
Chakraburtty, K. 2001. Translational regulation by ABC systems. Res. Microbiol. 152: 391–399.[Medline]
Dinman, J.D. 1995. Ribosomal frameshifting in yeast viruses. Yeast 11: 1115–1127.[CrossRef][Medline]
Doring, T., Mitchell, P., Osswald, M., Bochkariov, D., and Brimacombe, R. 1994. The decoding region of 16S RNA: A cross-linking study of the ribosomal A, P, and E sites using tRNA derivatized at position 32 in the anticodon loop. EMBO J. 13: 2677–2685.[Medline]
Dresios, J., Panopoulos, P., and Synetos, D. 2006. Eukaryotic ribosomal proteins lacking a eubacterial counterpart: Important players in ribosomal function. Mol. Microbiol. 59: 1651–1663.[CrossRef][Medline]
elBaradi, T.T., van der Sande, C.A., Mager, W.H., Raue, H.A., and Planta, R.J. 1986. The cellular level of yeast ribosomal protein L25 is controlled principally by rapid degradation of excess protein. Curr. Genet. 10: 733–739.[CrossRef][Medline]
Fernandez, J., Yaman, I., Mishra, R., Merrick, W.C., Snider, M.D., Lamers, W.H., and Hatzoglou, M. 2001. Internal ribosome entry site-mediated translation of a mammalian mRNA is regulated by amino acid availability. J. Biol. Chem. 276: 12285–12291.
Fleming, G., Belhumeur, P., Skup, D., and Fried, H.M. 1989. Functional substitution of mouse ribosomal protein L27' for yeast ribosomal protein L29 in yeast ribosomes. Proc. Natl. Acad. Sci. 86: 217–221.
Fredrick, K., Dunny, G.M., and Noller, H.F. 2000. Tagging ribosomal protein S7 allows rapid identification of mutants defective in assembly and function of 30 S subunits. J. Mol. Biol. 298: 379–394.[CrossRef][Medline]
Fukushi, S., Okada, M., Stahl, J., Kageyama, T., Hoshino, F.B., and Katayama, K. 2001. Ribosomal protein S5 interacts with the internal ribosomal entry site of hepatitis C virus. J. Biol. Chem. 276: 20824–20826.
Gaccioli, F., Huang, C.C., Wang, C., Bevilacqua, E., Franchi-Gazzola, R., Gazzola, G.C., Bussolati, O., Snider, M.D., and Hatzoglou, M. 2006. Amino acid starvation induces the SNAT2 neutral amino acid transporter by a mechanism that involves eukaryotic initiation factor 2
phosphorylation and cap-independent translation. J. Biol. Chem. 281: 17929–17940.
Gazda, H.T. and Sieff, C.A. 2006. Recent insights into the pathogenesis of Diamond-Blackfan anemia. Br. J. Haematol. 135: 149–157.[CrossRef][Medline]
Grondek, J.F. and Culver, G.M. 2004. Assembly of the 30S ribosomal subunit: Positioning ribosomal protein S13 in the S7 assembly branch. RNA 10: 1861–1866.
Harger, J.W. and Dinman, J.D. 2003. An in vivo dual-luciferase assay system for studying translational recoding in the yeast Saccharomyces cerevisiae. RNA 9: 1019–1024.
Harger, J.W. and Dinman, J.D. 2004. Evidence against a direct role for the Upf proteins in frameshifting or nonsense codon readthrough. RNA 10: 1721–1729.
Ignatovich, O., Cooper, M., Kulesza, H.M., and Beggs, J.D. 1995. Cloning and characterisation of the gene encoding the ribosomal protein S5 (also known as rp14, S2, YS8) of Saccharomyces cerevisiae . Nucleic Acids Res. 23: 4616–4619. doi: 10.1093/nar/23.22.4616.
Ihmels, J., Friedlander, G., Bergmann, S., Sarig, O., Ziv, Y., and Barkai, N. 2002. Revealing modular organization in the yeast transcriptional network. Nat. Genet. 31: 370–377.[CrossRef][Medline]
Ito, H., Fukuda, Y., Murata, K., and Kimura, A. 1983. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 53: 163–168.
Jacobs, J.L. and Dinman, J.D. 2004. Systematic analysis of bicistronic reporter assay data. Nucleic Acids Res. 32: e160. doi: 10.1093/nar/gnh157.
Jeeninga, R.E., Venema, J., and Raue, H.A. 1996. Rat RL23a ribosomal protein efficiently competes with its Saccharomyces cerevisiae L25 homologue for assembly into 60 S subunits. J. Mol. Biol. 263: 648–656.[CrossRef][Medline]
Kapasi, P., Chaudhuri, S., Vyas, K., Baus, D., Komar, A.A., Fox, P.L., Merrick, W.C., and Mazumder, B. 2007. L13a blocks 48S assembly: Role of a general initiation factor in mRNA-specific translational control. Mol. Cell 25: 113–126.[CrossRef][Medline]
Komar, A.A., Lesnik, T., Cullin, C., Merrick, W.C., Trachsel, H., and Altmann, M. 2003. Internal initiation drives the synthesis of Ure2 protein lacking the prion domain and affects [URE3] propagation in yeast cells. EMBO J. 22: 1199–1209.[CrossRef][Medline]
Komar, A.A., Gross, S.R., Barth-Baus, D., Strachan, R., Hensold, J.O., Goss Kinzy, T., and Merrick, W.C. 2005. Novel characteristics of the biological properties of the yeast Saccharomyces cerevisiae eukaryotic initiation factor 2A. J. Biol. Chem. 280: 15601–15611.
Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685.[CrossRef][Medline]
Laletina, E., Graifer, D., Malygin, A., Ivanov, A., Shatsky, I., and Karpova, G. 2006. Proteins surrounding hairpin IIIe of the hepatitis C virus internal ribosome entry site on the human 40S ribosomal subunit. Nucleic Acids Res. 34: 2027–2036. doi: 10.1093/nar/gkl155.
Maicas, E., Pluthero, F.G., and Friesen, J.D. 1988. The accumulation of three yeast ribosomal proteins under conditions of excess mRNA is determined primarily by fast protein decay. Mol. Cell. Biol. 8: 169–175.
Mazumder, B., Sampath, P., and Fox, P.L. 2006. Translational control of ceruloplasmin gene expression: Beyond the IRE. Biol. Res. 39: 59–66.[Medline]
Mitra, K. and Frank, J. 2006. Ribosome dynamics: Insights from atomic structure modeling into cryo-electron microscopy maps. Annu. Rev. Biophys. Biomol. Struct. 35: 299–317.[CrossRef][Medline]
Morimoto, K., Lin, S., and Sakamoto, K. 2006. The functions of RPS19 and their relationship to Diamond-Blackfan anemia: A review. Mol. Genet. Metab. 90: 358–362.